Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization;Einfluß der reagenzcharge auf die aktivierte partielle thromboplastinzeit in caninem plasma und anwendung des ratio-systems zur standardisierung

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 115, Issue 5-6, 2002, Pages 225-229

  Mischke, Reinhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Activated partial thromboplastin time; Dog; Ratio system; Reagent batches; Standardization

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANALYTICAL EQUIPMENT; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CALIBRATION; DOG; DOG DISEASE; METHODOLOGY; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CALIBRATION; DOG DISEASES; DOGS; INDICATORS AND REAGENTS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035984067     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. A survey of aPTT reporting in Canadian medical laboratories. The need for increased standardization
2. Establishing a therapeutic range for heparin therapy
3. Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT
4. Standardization of APTT reagents for heparin therapy monitoring: Urgent or fadig priority?
5. Diagnostic approaches to coagulation and fibrinolytic disorders
6. Comparison of reagents for determining the activated partial thromboplastin time
7. Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time
8. The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
9. Partial thromboplastin time test - Proposed performance guidelines. ICSH panel on the APTT
10. A comparison of different APTT-reagents, heparin-sensitivity and detection of mild coagulopathies
11. A multicenter evaluation of partial thromboplastin time reagents in the detection of mild haemophiliacs
12. Activated partial thromboplastin time as a screening test of minor or moderate coagulation factor deficiencies for canine plasma: Sensitivity of different commercial reagents
13. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios
14. An attempt to standardize APTT reagents used to monitor heparin therapy
15. An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study
16. The partial thromboplastin time with kaolin
17. Comparing different lots of activated partial thromboplastin time reagent: Analysis of two methods
18. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer
19. The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure
20. The APTT monitoring of heparin - The ISTH/ICSH collaborative study
21. Standards für die kontrolle von gerinnungsparametern